Terms: = Skin cancer AND TTL, 2410003M22Rik, 150465, ENSG00000114999, MGC46235, Q8NG68
1 results:
1. Antimetabolite ttl-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.
DuHadaway J; Prendergast GC
Oncotarget; 2016 Feb; 7(7):7372-80. PubMed ID: 26840263
[TBL] [Abstract] [Full Text] [Related]
